chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a minute after I had the vaccine, I had prickling feelings all over. I had big aches. Body aches and joint aches. I had pain that was in the arm and chest area. The more severe lasted a couple of hours while I was driving. What worries me is that they said side effects are more severe with the second dose than with the first dose. I really don?t want to experience something worse than what I had with the first one. I might have a better result with the Moderna. I was unvaccinated until the 9/11/2021 and I have not have Covid. I have followed all the guidelines and I have not gotten Covid. So getting the vaccine isn?t really much for me as it is for other people. I am worried to see that it works for me and if I cant get somebody to listen to me about this, I would not rather have another Pfizer vaccine, I would rather have the Moderna vaccine but if I can?t, then I will not get the second Pfizer vaccine. I will go to the doctor today because my PCP does not accept my insurance so I am going to another one. I have only called the pharmacies and doctor's offices and nobody has helped me.
Couple days after vaccine the inside of her lip started to tingle and burn. It went from the inside of the lip and moved to the out part. Her lips feel rough like peeling skin.
$ hours after vaccie area became very swollen, hard and red. Pt also felt extremely tired and achey of the next few days.
TIRED; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) one total, dose, start therapy date were not reported for prophylactic vaccination. The batch no was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced tired, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tired and fever was not reported. This report was non-serious.
A 42-year-old female patient received a TD Adult vaccination on 5/31/01 at 10:00am. Four hours after injection the patient developed a rash, pain and redness. These symptoms resolved and the patient recovered.
2 hr duration screaming fit the evening of 1st immun; was quite cranky x 6 hrs total; no high fever or other probs;
This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 67-year-old female patient who received SHINGRIX for prophylaxis. On 2nd April 2019, the patient received the 1st dose of SHINGRIX. On 5th April 2019, 3 days after receiving SHINGRIX, the patient experienced shingles, pain and pruritus. On an unknown date, the outcome of the shingles, pain and pruritus were not recovered/not resolved. It was unknown if the reporter considered the shingles, pain and pruritus to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a physician's assistant. The batch number and expiry date were not reported. On 5th April 2019, the patient developed pain and itching of the skin and at the day of reporting had full blown shingles.
My wife got very sick in late October; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (My wife got very sick in late October) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In October 2021, the patient experienced ILLNESS (My wife got very sick in late October). At the time of the report, ILLNESS (My wife got very sick in late October) outcome was unknown.            Patient is getting tested for Covid-19. No concomitant medication were provided. No treatment information were provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-Nov-2021: Follow-up received and contains NNI.
Edema, redness and warmth. The edema on the left arm is 5 cm greater than the unvaccinated arm.
Woke in the night with soreness in armpit and inside upper arm with swelling left. Cool compress, tylenol and antihistimine had on hand.  Is better. Less sore
Numbness started on the left side of my scalp and turned into tingling/itching as well. This continued to spread across my entire scalp, face and back of my neck I am still dealing with it. Injection site is also red, hard and swollen, fever, extreme headache, sharp pain through shoulder and spine
made patient sick; Initial information regarding an unsolicited valid non-serious case from a consumer via social media on 15-Dec-2020.  This case involved a 33 year old patient who made patient sick (Illness), while patient received vaccine INFLUENZA VACCINE.  The patient's past medical treatment included INFLUENZA VACCINE.  Concomitant medication was unknown.  On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number: unknown and expiration date: unknown) via unknown route in unknown administration site.    On an unknown date (latency unknown), after administration of INFLUENZA VACCINE, the patient made sick (illness).  Final diagnosis was illness.  It was not reported if the patient received a corrective treatment.  At the time of reporting, event outcome was unknown.  There would be no information available on batch number for this case.
she also had a bad pain in the left part of head and she was ended prescribed a Cortisone Shot.; This is a spontaneous report from a contactable female consumer (Patient) received from a Pfizer-sponsored program . A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced she also had a bad pain in the left part of head and she was ended prescribed a cortisone shot. The action taken in response to the event for bnt162b2 was not applicable. Therapeutic measures were taken as a result of she also had a bad pain in the left part of head and she was ended prescribed a cortisone shot. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Left arm is swollen; Left arm is hard; Left arm is red; Left arm is hot to the touch and warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Left arm is swollen), VACCINATION SITE INDURATION (Left arm is hard), VACCINATION SITE ERYTHEMA (Left arm is red) and VACCINATION SITE WARMTH (Left arm is hot to the touch and warm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Blood pressure medicine, Waterpill, Diabetic medication, Cholesterol pill and Bunch of vitamins for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Left arm is swollen), VACCINATION SITE INDURATION (Left arm is hard), VACCINATION SITE ERYTHEMA (Left arm is red) and VACCINATION SITE WARMTH (Left arm is hot to the touch and warm). At the time of the report, VACCINATION SITE SWELLING (Left arm is swollen), VACCINATION SITE INDURATION (Left arm is hard), VACCINATION SITE ERYTHEMA (Left arm is red) and VACCINATION SITE WARMTH (Left arm is hot to the touch and warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   She used Benadryl and Pain medicine for her symptoms
Started having numbness in face that felt like Novocain wearing off. A day later had issue with numbness and pain in elbow down to tips of  fingers on my arms from my carpal tunnel. By Friday, it seem to have worn off but that following Saturday a major change in my face drooping had occurred. Went to my Acupuncturist to see if they could give some sort of treatment for it. Gave acupuncture with light electrolysis and advised on facial exercises for treatment. This Bell's flare up left me with continuing tingling and droop.
onset of fever, swelling of right knee and distal leg, malaise, inability to bear weight on right lower extremity
Information has been received from a  pharmacist concerning a 70 year old female patient with a sulfa allergy, who on 4/25/05 at 13:00 was vaccinated subcutaneously in the RUQ with a 0.5 ml first dose of Pneumococcal 23v polysaccharide vaccine. Illness at the time of vaccination included a urinary tract infection and dehydration. At 20:00, the patient developed injection site redness, erythema, swelling and soreness. Unspecified medical attention was sought. The patient was treated with warm compresses. No diagnostic lab test were performed. Subsequently, the patient recovered. No product quality complaint was involved. Additional information is not expected.
12HRS AFTER VACCINATION THE FOLLOWING SYMPTOMS OCCURRED: NAUSEA/VOMITTING/CHILLS/ RIGHT SIDED HEADACHE/ LEFT SIDED BODY PAIN/ STIFF NECK, PROFOUND FATIGUE/ DIARRHEA. VOMITTING AND CHILLS LASTED FOR 4HRS.  THE REMAINING SYMPTOMS LASTED FOR 36 HRS.  FATIGUE, NAUSEA, AND DIARRHEA CONTINUE TO REMAIN 60 HRS AFTER RECEIVING THE VACCINE.
The lot numbers are really small on the paper I received I am not totally certain about the first two letter/numbers.  I have 9 cm erythematous very hot to touch firm knot on my arm and can hardly lift my left arm. I can use my right arm. I have low grade fever, shaking chills and a rash on my left arm that extends down to my elbow. I also have pronounced left axillary lymph nodes. I have taken 50 mg of Benadryl which has not helped. I also took 800 mg of Motrin because the pain in my arm and my back and hips and pelvis and legs feels like my bones are crushed. My left arm and my armpit pain up into my neck make it almost impossible to turn my head to the right. I?ve also had severe nausea, vomiting and diarrhea and unable to keep anything down since 10/1/2021.  I am a PA-C and clinically speaking this has been a significant reaction but I did not have anaphylaxis.
I was administered the shot by a nurse and was monitored for 15 min afterwards. I felt fine until later that day in the evening I started to notice some pain in the injection site and some redness and swelling. Early in the morning on the next day I was very tired and fatigued and the pain and swelling was visibly worse and lasted throughout the rest of the day into the evening. This morning I was still tired and fatigued but was noticeably better than the previous day. There is still some pain and redness and swelling but it is getting better. It should be noted I was given the shot on my right arm where a tattoo is located.
they both did not have vertigo or did not have the vertigo this severe with at least the first two doses of their Pfizer Covid vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 17 years as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "they both did not have vertigo or did not have the vertigo this severe with at least the first two doses of their Pfizer Covid vaccines".  Additional information: Prior Vaccinations (within 4 weeks) was none. Patients Medical History (including any illness at time of vaccination) was  none. Family Medical History Relevant to AE(s) was none. The patient no visited Emergency Room or Physician Office.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Two weeks after my second shot I started bleeding, it was rare because since I?m on child birth control (be plan on) I haven?t bleed at all since 3 years ago. It was okey because I though my cycle came back again. I got nausea, and a horrible cramp. The blood is dark and abundant (and I menstruate light). The bleeding was coming for the last two months (June and July) every two weeeks but then on the second week of august I started bleeding again and I haven?t stop.
Patient is hot, dizzy, blurry, black out (cannot see anything-black), sweating, warm but still responsive when I ask her questions. Her breathing seems ok. I get a wet paper towel and tap on her face to cool her down. Give her a sip of water here and there. Her husband said she hasn't eaten, then he bought a chocolate chip cookie and put a small amount in her mouth. She is eating and swallowing slowly. After about 7 minutes, she starts opening her eyes and see things around. We make a paper fan and cool her down. After approximately 7 more minutes she feels ok. She is alert and back to normal. I suggest her to wait for 10 more minutes. Then patient decides to leave. She leaves by her own and we give her and her husband instructions of emergency situations if happened.
Right side of head..mouth pain with guns, tongue, roof of mouth..eye  and ear pain.....following morning with cold sweats and weakness
arm and shoulder discomfort; shoulder pain; Initial information received on 21-Jun-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 74 years old female patient who experienced arm and shoulder discomfort and shoulder pain, while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  In January 2019, the patient received a dose of suspect 0.5 ml INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via unknown route in the left deltoid.  On an unknown date, following the vaccination the patient experienced limb discomfort and shoulder pain (musculoskeletal pain).  (Other relevant tests included no lab data.)  Final diagnosis was limb discomfort and shoulder pain.  The patient was treated with IBUPROFEN (IBUPROFEN), CORTISONE (CORTISONE) and arthritis cream.  The outcome of the events was reported as unknown at the time of reporting.  Information on the batch number was requested.  Documents held by sender: none.
Dizzy, arm swelling and soreness, general malaise, warm touch administration area. Negative for fever, or redness to administration area. Patient taking fluids, ibuprofen, Benadryl.
administered 0.25 ml instead of 0.5 ml to uncompromised adults/wrong dose for Bivalent Vaccine booster dose (underdose); No adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (administered 0.25 ml instead of 0.5 ml to uncompromised adults/wrong dose for Bivalent Vaccine booster dose (underdose)) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (administered 0.25 ml instead of 0.5 ml to uncompromised adults/wrong dose for Bivalent Vaccine booster dose (underdose)) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (administered 0.25 ml instead of 0.5 ml to uncompromised adults/wrong dose for Bivalent Vaccine booster dose (underdose)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (administered 0.25 ml instead of 0.5 ml to uncompromised adults/wrong dose for Bivalent Vaccine booster dose (underdose)).    Concomitant medications were not reported.   It was reported that approximately 100 patients were administered lower than authorized dose of the Moderna COVID-19 bivalent booster. It was reported when first administered Bivalent boosters. So, the nurse assumed the same dose as the second booster and they administered 0.25 ml instead of 0.5 ml to uncompromised adults. It was reported that no adverse event was reported. This case was for one of the patient among the 100 patients who were administered an invalid dose of the Moderna COVID-19 bivalent booster.  Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-646512 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-646512:Same reporter
pt devel 14x12 cm area of erythema on rt deltoid w/low grade temp;area is hard, well demarcated & pruritic;
THE PATIENT FELT UNWELL AND LIGHT HEADED AFTER GIVEN THE MODERNA VACCINATION.
I had Covid on 25 Nov. 2020.  I had extreme fatigue, shortness of breath, aching, headaches and abdominal pain. I have IBS which flared up during this time.  It took me December and January to finally get over the fatigue part. When I received my vaccination on Feb. 12, 2021 (Moderna) by that evening I began to run a temp. of 102-103. I had chills, headache, abdominal pain (worse than in Nov.), fatigue, some dizziness, and short of breath. I felt like I had Covid all over again!  I was down for 5 days. On Sunday afternoon, Feb 14 I went to the Clinic to see the doctor on call.  I was told they could not test me since I had Covid November 25 and it hadn't been 90 days and I would still have the antibodies.
Fatigue; Low grade temperature 100 degree; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and PYREXIA (Low grade temperature 100 degree) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included Hives, Urticaria, Fever from 13-Nov-2020 to 19-Mar-2021, Ache from 13-Nov-2020 to 19-Mar-2021, Pain from 13-Nov-2020 to 19-Mar-2021, Swelling from 13-Nov-2020 to 19-Mar-2021, Chills from 13-Nov-2020 to 19-Mar-2021, Nausea from 13-Nov-2020 to 19-Mar-2021, Vomiting from 13-Nov-2020 to 19-Mar-2021, Difficulty breathing from 13-Nov-2020 to 19-Mar-2021, Consciousness decreased from 13-Nov-2020 to 19-Mar-2021, Numbness from 13-Nov-2020 to 19-Mar-2021, Feeling hot from 13-Nov-2020 to 19-Mar-2021 and Hip replacement (Within one week was walking one mile and felt quite well). Previously administered products included for Product used for unknown indication: Levaquin. Past adverse reactions to the above products included Muscle ache with Levaquin. Concurrent medical conditions included Hypersensitivity reaction and High cholesterol (Improved with rosuvastatin). Concomitant products included ESCITALOPRAM for Anxiety, ROSUVASTATIN for Cholesterol.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue) and PYREXIA (Low grade temperature 100 degree). At the time of the report, FATIGUE (Fatigue) and PYREXIA (Low grade temperature 100 degree) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (Low) Low grade temperature 100 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported. Patient was not pregnant. Patient took suspect drug on site of left arm in full dose at AM. It was reported that patient got cold temps in 2015 and had a reaction of rash/hives on exposed skin.   This case was linked to MOD-2021-419387, MOD-2021-419309 (Patient Link).
Information has been received from a physician concerning a 15 year old female with no past medical history who on 22-JAN-2007 was vaccinated IM with a second 0.5 ml dose of HPV vaccine (yeast) (lot #655617/1447F). There was no concomitant medication. On 29-JAN-2007 the patient developed erythema and mild tenderness at the site of injection. There was no fever. She sought unspecified medical attention.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 2/14/2007.  Initial and follow up information has been received from a physician concering a 15 year old female student with no past medical history and no adverse events following prior vaccinations who on 22-JAN-2007 was vaccinated IM with a second 0.5ml dose of GARDASIL (lot # 655617/1447F).  There was no concomitant medication.  On 29-JAN-2007 the patient developed erythema, swelling and mild tenderness at the site of injection.  There was no fever.  She recovered on an unspecified date.  Additional information is not expected.